XML 87 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Statement of Cash Flows (USD $)
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ 184,644,000 $ 145,401,000 $ 114,095,000
Adjustments to reconcile income to net cash provided by operating activities:      
Net provision for (recoveries of) doubtful accounts 254,000 1,444,000 545,000
Provision for inventory obsolescence 552,000 643,000 807,000
Equity in earnings of affiliates (274,000) (376,000) (92,000)
Share-based Compensation 17,165,000 8,517,000 5,896,000
Depreciation and amortization 23,303,000 23,113,000 23,818,000
Debt issuance costs amortization and finance charges 5,956,000 15,087,000 14,688,000
(Gain) loss on sale of assets (487,000) (176,000) 90,000
Gain on insurance recovery (1,014,000) 0 0
Loss on exchange of Senior Exchangeable Notes 1,012,000 1,939,000 0
Realization of pension obligation 303,000 137,000 364,000
(Increase) decrease in value of life insurance policies 285,000 (1,950,000) (1,997,000)
Deferred Income Tax Expense (Benefit) (6,549,000) (10,135,000) 25,636,000
Changes in assets and liabilities, net of effects of acquisitions:      
Accounts receivable (12,082,000) (22,412,000) 9,990,000
Inventories (16,033,000) (2,438,000) 1,847,000
Prepaid expenses and other current assets (1,228,000) 21,455,000 (27,762,000)
Other assets 680,000 (102,000) (1,060,000)
Accounts payable 11,969,000 11,701,000 (8,579,000)
Accrued expenses (13,754,000) 13,701,000 18,813,000
Other long-term liabilities 9,424,000 283,000 4,774,000
Net cash provided by operating activities 204,126,000 205,832,000 181,873,000
CASH FLOWS FROM INVESTING ACTIVITIES:      
Capital expenditures (29,927,000) (27,569,000) (17,289,000)
Patents and other intangibles (220,000) (233,000) (240,000)
Acquisitions, net of cash acquired (18,821,000) (9,000,000) 0
Cash in escrow (2,179,000) 0 0
Proceeds from sale of assets 900,000 669,000 584,000
Proceeds from insurance recovery 1,300,000 0 0
Premiums on life insurance (3,071,000) (2,604,000) (1,595,000)
Net cash used in investing activities (52,018,000) (38,737,000) (18,540,000)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Repayment of debt borrowings (348,564,000) (82,251,000) 0
Proceeds from debt borrowings 417,426,000 0 0
Stock options exercised 297,000 346,000 408,000
Excess tax benefits from stock-based payments 2,559,000 967,000 170,000
Debt financing costs (2,014,000) (1,019,000) 0
Settlement of Warrants (219,451,000) 0 0
Non-controlling interest - contributions 1,194,000 156,000 0
Non-controlling interest - dividend (251,000) (181,000) (259,000)
Dividends paid (46,027,000) (39,791,000) (26,416,000)
Repurchase of common shares (61,825,000) (92,487,000) (9,389,000)
Proceeds from sale of note hedge claim 0 0 17,060,000
Net cash used in financing activities (256,656,000) (214,260,000) (18,426,000)
NET CHANGE IN CASH AND CASH EQUIVALENTS (104,548,000) (47,165,000) 144,907,000
Cash and Cash Equivalents, at Carrying Value 29,332,000 133,880,000 181,045,000
Cash payments for interest 2,308,000 566,000 597,000
Cash payments for income taxes 74,724,000 57,259,000 41,703,000
Financed capital expenditures $ 1,273,000 $ 0 $ 1,810,000